IDERA PHARMACEUTICALS, INC. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jun 15, 2016
Insider Transaction Report
Form 4
REARDON WILLIAM S
Director
Transactions
- Award
Stock Option
2016-06-13+35,000→ 35,000 totalExercise: $1.44Exp: 2026-06-13→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]The option was automatically granted pursuant to the Company's director compensation program on the date of the Company's 2016 annual meeting of stockholders at an exercise price equal to the closing price of the Company's common stock on the date of grant.
- [F2]The option vests with respect to one third of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in eight equal quarterly installments following the first anniversary of the date of grant, subject to continued service as a director, and are granted under our 2013 Stock Incentive Plan